The global market for Bioengineered Protein Drugs was valued at US$ 90590 million in the year 2024 and is projected to reach a revised size of US$ 118950 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Bioengineered Protein Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Bioengineered Protein Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioengineered Protein Drugs.

The Bioengineered Protein Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bioengineered Protein Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bioengineered Protein Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Bioengineered Protein Drugs Market Report

Report Metric	Details
Report Name	Bioengineered Protein Drugs Market
Accounted market size in year	US$ 90590 million
Forecasted market size in 2031	US$ 118950 million
CAGR	4.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Monoclonal Antibodies Therapeutic Proteins Vaccines
Segment by Application	Cancer Diabetes Autoimmune Disorder Infectious Disease Neurodegenerative Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Dr.Reddy’s, Eli Lilly, Merck, Reliance Life Sciences, Panacea Biotech, Novartis, Fresenius, Sanofi, ProBioGen, GlaxoSmithKline, Roche, Amoytop Biotech, Shanghai United Cell Biotechnology, Hualan Bio
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bioengineered Protein Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bioengineered Protein Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Bioengineered Protein Drugs Market growing?

Ans: The Bioengineered Protein Drugs Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Bioengineered Protein Drugs Market size in 2031?

Ans: The Bioengineered Protein Drugs Market size in 2031 will be US$ 118950 million.

Who are the main players in the Bioengineered Protein Drugs Market report?

Ans: The main players in the Bioengineered Protein Drugs Market are Dr.Reddy’s, Eli Lilly, Merck, Reliance Life Sciences, Panacea Biotech, Novartis, Fresenius, Sanofi, ProBioGen, GlaxoSmithKline, Roche, Amoytop Biotech, Shanghai United Cell Biotechnology, Hualan Bio

What are the Application segmentation covered in the Bioengineered Protein Drugs Market report?

Ans: The Applications covered in the Bioengineered Protein Drugs Market report are Cancer, Diabetes, Autoimmune Disorder, Infectious Disease, Neurodegenerative, Others

What are the Type segmentation covered in the Bioengineered Protein Drugs Market report?

Ans: The Types covered in the Bioengineered Protein Drugs Market report are Monoclonal Antibodies, Therapeutic Proteins, Vaccines

1 Bioengineered Protein Drugs Market Overview

1.1 Product Definition

1.2 Bioengineered Protein Drugs by Type

1.2.1 Global Bioengineered Protein Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Monoclonal Antibodies

1.2.3 Therapeutic Proteins

1.2.4 Vaccines

1.3 Bioengineered Protein Drugs by Application

1.3.1 Global Bioengineered Protein Drugs Market Value by Application (2024 VS 2031)

1.3.2 Cancer

1.3.3 Diabetes

1.3.4 Autoimmune Disorder

1.3.5 Infectious Disease

1.3.6 Neurodegenerative

1.3.7 Others

1.4 Global Bioengineered Protein Drugs Market Size Estimates and Forecasts

1.4.1 Global Bioengineered Protein Drugs Revenue 2020-2031

1.4.2 Global Bioengineered Protein Drugs Sales 2020-2031

1.4.3 Global Bioengineered Protein Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Bioengineered Protein Drugs Market Competition by Manufacturers

2.1 Global Bioengineered Protein Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Bioengineered Protein Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Bioengineered Protein Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Bioengineered Protein Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bioengineered Protein Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bioengineered Protein Drugs, Product Type & Application

2.7 Global Key Manufacturers of Bioengineered Protein Drugs, Date of Enter into This Industry

2.8 Global Bioengineered Protein Drugs Market Competitive Situation and Trends

2.8.1 Global Bioengineered Protein Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Bioengineered Protein Drugs Players Market Share by Revenue

2.8.3 Global Bioengineered Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Bioengineered Protein Drugs Market Scenario by Region

3.1 Global Bioengineered Protein Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Bioengineered Protein Drugs Sales by Region: 2020-2031

3.2.1 Global Bioengineered Protein Drugs Sales by Region: 2020-2025

3.2.2 Global Bioengineered Protein Drugs Sales by Region: 2026-2031

3.3 Global Bioengineered Protein Drugs Revenue by Region: 2020-2031

3.3.1 Global Bioengineered Protein Drugs Revenue by Region: 2020-2025

3.3.2 Global Bioengineered Protein Drugs Revenue by Region: 2026-2031

3.4 North America Bioengineered Protein Drugs Market Facts & Figures by Country

3.4.1 North America Bioengineered Protein Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Bioengineered Protein Drugs Sales by Country (2020-2031)

3.4.3 North America Bioengineered Protein Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Bioengineered Protein Drugs Market Facts & Figures by Country

3.5.1 Europe Bioengineered Protein Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Bioengineered Protein Drugs Sales by Country (2020-2031)

3.5.3 Europe Bioengineered Protein Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bioengineered Protein Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Bioengineered Protein Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Bioengineered Protein Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Bioengineered Protein Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Bioengineered Protein Drugs Market Facts & Figures by Country

3.7.1 Latin America Bioengineered Protein Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Bioengineered Protein Drugs Sales by Country (2020-2031)

3.7.3 Latin America Bioengineered Protein Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bioengineered Protein Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Bioengineered Protein Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Bioengineered Protein Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Bioengineered Protein Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Bioengineered Protein Drugs Sales by Type (2020-2031)

4.1.1 Global Bioengineered Protein Drugs Sales by Type (2020-2025)

4.1.2 Global Bioengineered Protein Drugs Sales by Type (2026-2031)

4.1.3 Global Bioengineered Protein Drugs Sales Market Share by Type (2020-2031)

4.2 Global Bioengineered Protein Drugs Revenue by Type (2020-2031)

4.2.1 Global Bioengineered Protein Drugs Revenue by Type (2020-2025)

4.2.2 Global Bioengineered Protein Drugs Revenue by Type (2026-2031)

4.2.3 Global Bioengineered Protein Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Bioengineered Protein Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Bioengineered Protein Drugs Sales by Application (2020-2031)

5.1.1 Global Bioengineered Protein Drugs Sales by Application (2020-2025)

5.1.2 Global Bioengineered Protein Drugs Sales by Application (2026-2031)

5.1.3 Global Bioengineered Protein Drugs Sales Market Share by Application (2020-2031)

5.2 Global Bioengineered Protein Drugs Revenue by Application (2020-2031)

5.2.1 Global Bioengineered Protein Drugs Revenue by Application (2020-2025)

5.2.2 Global Bioengineered Protein Drugs Revenue by Application (2026-2031)

5.2.3 Global Bioengineered Protein Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Bioengineered Protein Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Dr.Reddy’s

6.1.1 Dr.Reddy’s Company Information

6.1.2 Dr.Reddy’s Description and Business Overview

6.1.3 Dr.Reddy’s Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Dr.Reddy’s Bioengineered Protein Drugs Product Portfolio

6.1.5 Dr.Reddy’s Recent Developments/Updates

6.2 Eli Lilly

6.2.1 Eli Lilly Company Information

6.2.2 Eli Lilly Description and Business Overview

6.2.3 Eli Lilly Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Eli Lilly Bioengineered Protein Drugs Product Portfolio

6.2.5 Eli Lilly Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merck Bioengineered Protein Drugs Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Reliance Life Sciences

6.4.1 Reliance Life Sciences Company Information

6.4.2 Reliance Life Sciences Description and Business Overview

6.4.3 Reliance Life Sciences Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Reliance Life Sciences Bioengineered Protein Drugs Product Portfolio

6.4.5 Reliance Life Sciences Recent Developments/Updates

6.5 Panacea Biotech

6.5.1 Panacea Biotech Company Information

6.5.2 Panacea Biotech Description and Business Overview

6.5.3 Panacea Biotech Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Panacea Biotech Bioengineered Protein Drugs Product Portfolio

6.5.5 Panacea Biotech Recent Developments/Updates

6.6 Novartis

6.6.1 Novartis Company Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Novartis Bioengineered Protein Drugs Product Portfolio

6.6.5 Novartis Recent Developments/Updates

6.7 Fresenius

6.7.1 Fresenius Company Information

6.7.2 Fresenius Description and Business Overview

6.7.3 Fresenius Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Fresenius Bioengineered Protein Drugs Product Portfolio

6.7.5 Fresenius Recent Developments/Updates

6.8 Sanofi

6.8.1 Sanofi Company Information

6.8.2 Sanofi Description and Business Overview

6.8.3 Sanofi Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sanofi Bioengineered Protein Drugs Product Portfolio

6.8.5 Sanofi Recent Developments/Updates

6.9 ProBioGen

6.9.1 ProBioGen Company Information

6.9.2 ProBioGen Description and Business Overview

6.9.3 ProBioGen Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 ProBioGen Bioengineered Protein Drugs Product Portfolio

6.9.5 ProBioGen Recent Developments/Updates

6.10 GlaxoSmithKline

6.10.1 GlaxoSmithKline Company Information

6.10.2 GlaxoSmithKline Description and Business Overview

6.10.3 GlaxoSmithKline Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 GlaxoSmithKline Bioengineered Protein Drugs Product Portfolio

6.10.5 GlaxoSmithKline Recent Developments/Updates

6.11 Roche

6.11.1 Roche Company Information

6.11.2 Roche Description and Business Overview

6.11.3 Roche Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Roche Bioengineered Protein Drugs Product Portfolio

6.11.5 Roche Recent Developments/Updates

6.12 Amoytop Biotech

6.12.1 Amoytop Biotech Company Information

6.12.2 Amoytop Biotech Description and Business Overview

6.12.3 Amoytop Biotech Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Amoytop Biotech Bioengineered Protein Drugs Product Portfolio

6.12.5 Amoytop Biotech Recent Developments/Updates

6.13 Shanghai United Cell Biotechnology

6.13.1 Shanghai United Cell Biotechnology Company Information

6.13.2 Shanghai United Cell Biotechnology Description and Business Overview

6.13.3 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product Portfolio

6.13.5 Shanghai United Cell Biotechnology Recent Developments/Updates

6.14 Hualan Bio

6.14.1 Hualan Bio Company Information

6.14.2 Hualan Bio Description and Business Overview

6.14.3 Hualan Bio Bioengineered Protein Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Hualan Bio Bioengineered Protein Drugs Product Portfolio

6.14.5 Hualan Bio Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bioengineered Protein Drugs Industry Chain Analysis

7.2 Bioengineered Protein Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bioengineered Protein Drugs Production Mode & Process Analysis

7.4 Bioengineered Protein Drugs Sales and Marketing

7.4.1 Bioengineered Protein Drugs Sales Channels

7.4.2 Bioengineered Protein Drugs Distributors

7.5 Bioengineered Protein Drugs Customer Analysis

8 Bioengineered Protein Drugs Market Dynamics

8.1 Bioengineered Protein Drugs Industry Trends

8.2 Bioengineered Protein Drugs Market Drivers

8.3 Bioengineered Protein Drugs Market Challenges

8.4 Bioengineered Protein Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Reliance Life Sciences

Shanghai United Cell Biotechnology

Hualan Bio

List of Tables

Table 1. Global Bioengineered Protein Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Bioengineered Protein Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Bioengineered Protein Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Bioengineered Protein Drugs Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Bioengineered Protein Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Bioengineered Protein Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Bioengineered Protein Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Bioengineered Protein Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Bioengineered Protein Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bioengineered Protein Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bioengineered Protein Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Bioengineered Protein Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bioengineered Protein Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bioengineered Protein Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bioengineered Protein Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Bioengineered Protein Drugs Sales by Region (2020-2025) & (Units)

Table 18. Global Bioengineered Protein Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Bioengineered Protein Drugs Sales by Region (2026-2031) & (Units)

Table 20. Global Bioengineered Protein Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Bioengineered Protein Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Bioengineered Protein Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Bioengineered Protein Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Bioengineered Protein Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Bioengineered Protein Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)

Table 27. North America Bioengineered Protein Drugs Sales by Country (2026-2031) & (Units)

Table 28. North America Bioengineered Protein Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Bioengineered Protein Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Bioengineered Protein Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)

Table 32. Europe Bioengineered Protein Drugs Sales by Country (2026-2031) & (Units)

Table 33. Europe Bioengineered Protein Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Bioengineered Protein Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Bioengineered Protein Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Bioengineered Protein Drugs Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Bioengineered Protein Drugs Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Bioengineered Protein Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Bioengineered Protein Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bioengineered Protein Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)

Table 42. Latin America Bioengineered Protein Drugs Sales by Country (2026-2031) & (Units)

Table 43. Latin America Bioengineered Protein Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Bioengineered Protein Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Bioengineered Protein Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Bioengineered Protein Drugs Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Bioengineered Protein Drugs Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Bioengineered Protein Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Bioengineered Protein Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Bioengineered Protein Drugs Sales (Units) by Type (2020-2025)

Table 51. Global Bioengineered Protein Drugs Sales (Units) by Type (2026-2031)

Table 52. Global Bioengineered Protein Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Bioengineered Protein Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Bioengineered Protein Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Bioengineered Protein Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Bioengineered Protein Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Bioengineered Protein Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Bioengineered Protein Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Bioengineered Protein Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Bioengineered Protein Drugs Sales (Units) by Application (2020-2025)

Table 61. Global Bioengineered Protein Drugs Sales (Units) by Application (2026-2031)

Table 62. Global Bioengineered Protein Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Bioengineered Protein Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Bioengineered Protein Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Bioengineered Protein Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Bioengineered Protein Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Bioengineered Protein Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Bioengineered Protein Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Bioengineered Protein Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Dr.Reddy’s Company Information

Table 71. Dr.Reddy’s Description and Business Overview

Table 72. Dr.Reddy’s Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Dr.Reddy’s Bioengineered Protein Drugs Product

Table 74. Dr.Reddy’s Recent Developments/Updates

Table 75. Eli Lilly Company Information

Table 76. Eli Lilly Description and Business Overview

Table 77. Eli Lilly Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Eli Lilly Bioengineered Protein Drugs Product

Table 79. Eli Lilly Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Merck Bioengineered Protein Drugs Product

Table 84. Merck Recent Developments/Updates

Table 85. Reliance Life Sciences Company Information

Table 86. Reliance Life Sciences Description and Business Overview

Table 87. Reliance Life Sciences Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Reliance Life Sciences Bioengineered Protein Drugs Product

Table 89. Reliance Life Sciences Recent Developments/Updates

Table 90. Panacea Biotech Company Information

Table 91. Panacea Biotech Description and Business Overview

Table 92. Panacea Biotech Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Panacea Biotech Bioengineered Protein Drugs Product

Table 94. Panacea Biotech Recent Developments/Updates

Table 95. Novartis Company Information

Table 96. Novartis Description and Business Overview

Table 97. Novartis Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Novartis Bioengineered Protein Drugs Product

Table 99. Novartis Recent Developments/Updates

Table 100. Fresenius Company Information

Table 101. Fresenius Description and Business Overview

Table 102. Fresenius Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Fresenius Bioengineered Protein Drugs Product

Table 104. Fresenius Recent Developments/Updates

Table 105. Sanofi Company Information

Table 106. Sanofi Description and Business Overview

Table 107. Sanofi Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Sanofi Bioengineered Protein Drugs Product

Table 109. Sanofi Recent Developments/Updates

Table 110. ProBioGen Company Information

Table 111. ProBioGen Description and Business Overview

Table 112. ProBioGen Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. ProBioGen Bioengineered Protein Drugs Product

Table 114. ProBioGen Recent Developments/Updates

Table 115. GlaxoSmithKline Company Information

Table 116. GlaxoSmithKline Description and Business Overview

Table 117. GlaxoSmithKline Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. GlaxoSmithKline Bioengineered Protein Drugs Product

Table 119. GlaxoSmithKline Recent Developments/Updates

Table 120. Roche Company Information

Table 121. Roche Description and Business Overview

Table 122. Roche Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Roche Bioengineered Protein Drugs Product

Table 124. Roche Recent Developments/Updates

Table 125. Amoytop Biotech Company Information

Table 126. Amoytop Biotech Description and Business Overview

Table 127. Amoytop Biotech Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Amoytop Biotech Bioengineered Protein Drugs Product

Table 129. Amoytop Biotech Recent Developments/Updates

Table 130. Shanghai United Cell Biotechnology Company Information

Table 131. Shanghai United Cell Biotechnology Description and Business Overview

Table 132. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Shanghai United Cell Biotechnology Bioengineered Protein Drugs Product

Table 134. Shanghai United Cell Biotechnology Recent Developments/Updates

Table 135. Hualan Bio Company Information

Table 136. Hualan Bio Description and Business Overview

Table 137. Hualan Bio Bioengineered Protein Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Hualan Bio Bioengineered Protein Drugs Product

Table 139. Hualan Bio Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Bioengineered Protein Drugs Distributors List

Table 143. Bioengineered Protein Drugs Customers List

Table 144. Bioengineered Protein Drugs Market Trends

Table 145. Bioengineered Protein Drugs Market Drivers

Table 146. Bioengineered Protein Drugs Market Challenges

Table 147. Bioengineered Protein Drugs Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Bioengineered Protein Drugs

Figure 2. Global Bioengineered Protein Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bioengineered Protein Drugs Market Share by Type: 2024 & 2031

Figure 4. Monoclonal Antibodies Product Picture

Figure 5. Therapeutic Proteins Product Picture

Figure 6. Vaccines Product Picture

Figure 7. Global Bioengineered Protein Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Bioengineered Protein Drugs Market Share by Application: 2024 & 2031

Figure 9. Cancer

Figure 10. Diabetes

Figure 11. Autoimmune Disorder

Figure 12. Infectious Disease

Figure 13. Neurodegenerative

Figure 14. Others

Figure 15. Global Bioengineered Protein Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Bioengineered Protein Drugs Market Size (2020-2031) & (US$ Million)

Figure 17. Global Bioengineered Protein Drugs Sales (2020-2031) & (Units)

Figure 18. Global Bioengineered Protein Drugs Average Price (USD/Unit) & (2020-2031)

Figure 19. Bioengineered Protein Drugs Report Years Considered

Figure 20. Bioengineered Protein Drugs Sales Share by Manufacturers in 2024

Figure 21. Global Bioengineered Protein Drugs Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Bioengineered Protein Drugs Players: Market Share by Revenue in Bioengineered Protein Drugs in 2024

Figure 23. Bioengineered Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Bioengineered Protein Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Bioengineered Protein Drugs Sales Market Share by Country (2020-2031)

Figure 26. North America Bioengineered Protein Drugs Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Bioengineered Protein Drugs Sales Market Share by Country (2020-2031)

Figure 30. Europe Bioengineered Protein Drugs Revenue Market Share by Country (2020-2031)

Figure 31. Germany Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Bioengineered Protein Drugs Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Bioengineered Protein Drugs Revenue Market Share by Region (2020-2031)

Figure 38. China Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Bioengineered Protein Drugs Sales Market Share by Country (2020-2031)

Figure 49. Latin America Bioengineered Protein Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Bioengineered Protein Drugs Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Bioengineered Protein Drugs Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Bioengineered Protein Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Bioengineered Protein Drugs by Type (2020-2031)

Figure 59. Global Revenue Market Share of Bioengineered Protein Drugs by Type (2020-2031)

Figure 60. Global Bioengineered Protein Drugs Price (USD/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Bioengineered Protein Drugs by Application (2020-2031)

Figure 62. Global Revenue Market Share of Bioengineered Protein Drugs by Application (2020-2031)

Figure 63. Global Bioengineered Protein Drugs Price (USD/Unit) by Application (2020-2031)

Figure 64. Bioengineered Protein Drugs Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions